USD 10.96
(-8.21%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -46.11 Million USD | -12.95% |
2022 | -33.69 Million USD | -37.72% |
2021 | -23.99 Million USD | -16.73% |
2020 | -23.78 Million USD | -15.68% |
2019 | -2.34 Million USD | 31.83% |
2018 | -10.81 Million USD | -48.5% |
2017 | -23.1 Million USD | -11.03% |
2016 | -3.33 Million USD | -2.18% |
2015 | -14.08 Million USD | 25.76% |
2014 | -16.42 Million USD | 33.34% |
2013 | -29.19 Million USD | 39.31% |
2012 | -52.54 Million USD | 15.32% |
2011 | -29.85 Million USD | -333.14% |
2010 | -46.21 Million USD | -190.27% |
2009 | -22.04 Million USD | 38.8% |
2008 | -6.85 Million USD | 16.27% |
2007 | -3.65 Million USD | 18.57% |
2006 | -10.94 Million USD | -280.65% |
2005 | -2.85 Million USD | 7.6% |
2004 | -3.26 Million USD | -46.04% |
2003 | -2.3 Million USD | -21.72% |
2002 | -1.89 Million USD | 8.38% |
2001 | -2.06 Million USD | -100.6% |
2000 | -1.02 Million USD | -90.5% |
1999 | -540 Thousand USD | 72.73% |
1998 | -1.98 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -3.81 Million USD | -24.57% |
2024 Q1 | -10.24 Million USD | 1.91% |
2023 Q3 | -10.55 Million USD | -32.58% |
2023 FY | - USD | -12.95% |
2023 Q2 | -7.96 Million USD | 3.86% |
2023 Q1 | -8.28 Million USD | 12.49% |
2023 Q4 | -11.26 Million USD | -6.7% |
2022 Q3 | -7.7 Million USD | 14.28% |
2022 Q1 | -7.52 Million USD | -61.35% |
2022 Q2 | -8.99 Million USD | -19.46% |
2022 Q4 | -9.46 Million USD | -22.78% |
2022 FY | - USD | -37.72% |
2021 FY | - USD | -16.73% |
2021 Q4 | -4.66 Million USD | 30.04% |
2021 Q3 | -6.66 Million USD | -4.99% |
2021 Q2 | -6.35 Million USD | 4.74% |
2021 Q1 | -6.66 Million USD | 4.87% |
2020 Q4 | -7 Million USD | -47.32% |
2020 Q3 | -4.75 Million USD | -18.45% |
2020 Q1 | -4.75 Million USD | -6.71% |
2020 Q2 | -4.01 Million USD | 15.51% |
2020 FY | - USD | -15.68% |
2019 Q2 | -3.51 Million USD | 37.26% |
2019 FY | - USD | 31.83% |
2019 Q4 | -4.45 Million USD | 1.87% |
2019 Q3 | -4.53 Million USD | -29.06% |
2019 Q1 | -5.6 Million USD | 25.34% |
2018 FY | - USD | -48.5% |
2018 Q2 | -5.98 Million USD | 19.04% |
2018 Q3 | -5.69 Million USD | 4.73% |
2018 Q4 | -7.5 Million USD | -31.78% |
2018 Q1 | -7.38 Million USD | -60.23% |
2017 Q4 | -4.61 Million USD | -1.21% |
2017 Q3 | -4.55 Million USD | -0.18% |
2017 Q2 | -4.54 Million USD | 15.53% |
2017 Q1 | -5.38 Million USD | -210.71% |
2017 FY | - USD | -11.03% |
2016 Q1 | -5.02 Million USD | -48.73% |
2016 Q3 | -13.34 Million USD | -1243.71% |
2016 Q2 | -993 Thousand USD | 80.23% |
2016 FY | - USD | -2.18% |
2016 Q4 | 4.86 Million USD | 136.45% |
2015 FY | - USD | 25.76% |
2015 Q3 | -4.73 Million USD | -40.15% |
2015 Q1 | -3.73 Million USD | -3.18% |
2015 Q4 | -3.37 Million USD | 28.69% |
2015 Q2 | -3.38 Million USD | 9.38% |
2014 FY | - USD | 33.34% |
2014 Q2 | -6.95 Million USD | -51.57% |
2014 Q1 | -4.59 Million USD | 12.82% |
2014 Q4 | -3.61 Million USD | 31.86% |
2014 Q3 | -5.3 Million USD | 23.75% |
2013 Q2 | -10.27 Million USD | -3.86% |
2013 FY | - USD | 39.31% |
2013 Q4 | -5.26 Million USD | 18.22% |
2013 Q3 | -6.43 Million USD | 37.35% |
2013 Q1 | -9.89 Million USD | 5.71% |
2012 FY | - USD | 15.32% |
2012 Q4 | -10.49 Million USD | 14.52% |
2012 Q1 | -13.89 Million USD | 15.1% |
2012 Q2 | -15.85 Million USD | -14.12% |
2012 Q3 | -12.27 Million USD | 22.58% |
2011 FY | - USD | -333.14% |
2011 Q1 | -13.56 Million USD | -277.94% |
2011 Q2 | -15.27 Million USD | -12.6% |
2011 Q3 | -16.05 Million USD | -5.11% |
2011 Q4 | -16.36 Million USD | -1.94% |
2010 FY | - USD | -190.27% |
2010 Q2 | -8.82 Million USD | -370.63% |
2010 Q1 | 3.26 Million USD | -6.47% |
2010 Q3 | -5.16 Million USD | 41.46% |
2010 Q4 | -3.58 Million USD | 30.53% |
2009 Q2 | -2.72 Million USD | -98.14% |
2009 Q3 | -3.81 Million USD | -40.26% |
2009 Q4 | 3.48 Million USD | 191.38% |
2009 FY | - USD | 38.8% |
2009 Q1 | -1.37 Million USD | 47.63% |
2008 FY | - USD | 16.27% |
2008 Q4 | -2.62 Million USD | 24.96% |
2008 Q3 | -3.49 Million USD | -276.76% |
2008 Q2 | -927.25 Thousand USD | 43.05% |
2008 Q1 | -1.62 Million USD | -12.91% |
2007 Q3 | -1.81 Million USD | 20.02% |
2007 Q2 | -2.26 Million USD | -63.16% |
2007 Q1 | -1.38 Million USD | 63.22% |
2007 FY | - USD | 18.57% |
2007 Q4 | -1.44 Million USD | 20.43% |
2006 Q4 | -3.77 Million USD | 22.4% |
2006 Q3 | -4.86 Million USD | -182.07% |
2006 FY | - USD | -280.65% |
2006 Q2 | -1.72 Million USD | -30.0% |
2006 Q1 | -1.32 Million USD | -73.84% |
2005 Q4 | -763.36 Thousand USD | -4.05% |
2005 Q3 | -733.63 Thousand USD | -8.94% |
2005 Q2 | -673.43 Thousand USD | 30.22% |
2005 Q1 | -965.1 Thousand USD | -3.36% |
2005 FY | - USD | 7.6% |
2004 Q4 | -933.74 Thousand USD | -9.81% |
2004 FY | - USD | -46.04% |
2004 Q3 | -850.31 Thousand USD | 1.32% |
2004 Q2 | -861.73 Thousand USD | -20.48% |
2004 Q1 | -715.23 Thousand USD | -31.22% |
2003 FY | - USD | -21.72% |
2003 Q1 | -537.01 Thousand USD | -28.55% |
2003 Q4 | -545.06 Thousand USD | 19.49% |
2003 Q3 | -676.99 Thousand USD | -24.84% |
2003 Q2 | -542.28 Thousand USD | -0.98% |
2002 Q2 | -422.04 Thousand USD | 29.31% |
2002 Q1 | -597.06 Thousand USD | 1.02% |
2002 FY | - USD | 8.38% |
2002 Q4 | -417.74 Thousand USD | 7.94% |
2002 Q3 | -453.78 Thousand USD | -7.52% |
2001 Q3 | -439.03 Thousand USD | 20.49% |
2001 Q2 | -552.18 Thousand USD | -17.69% |
2001 Q1 | -469.2 Thousand USD | 0.17% |
2001 FY | - USD | -100.6% |
2001 Q4 | -603.2 Thousand USD | -37.39% |
2000 Q4 | -470 Thousand USD | -201.01% |
2000 Q3 | -156.14 Thousand USD | 8.15% |
2000 Q1 | -200 Thousand USD | -17.65% |
2000 Q2 | -170 Thousand USD | 15.0% |
2000 FY | - USD | -90.5% |
1999 FY | - USD | 72.73% |
1999 Q4 | -170 Thousand USD | 10.53% |
1999 Q3 | -190 Thousand USD | 0.0% |
1998 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Accuray Incorporated | 5.7 Million USD | 907.69% |
Envoy Medical, Inc. | -18.23 Million USD | -152.829% |
Xylo Technologies Ltd. | -12.18 Million USD | -278.331% |